表紙
市場調查報告書
商品編碼
1037222

一般外科用設備的全球市場 (2021-2026年):產業趨勢·市場佔有率·市場規模·成長預測·成長機會

General Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球一般外科用設備的市場規模在2015年到2020年呈現緩慢的成長,在預測期間內預計將以6%的年複合成長率成長。

隨著心臟和胃腸道疾病患者數量的增加,手術量的增加是推動市場增長的關鍵因素之一。老年人口的增加也支撐了市場,老年人口在圍手術期容易出現並發症。此外,一些國家的政府機構正在努力提供先進的手術設備和培訓課程。

本報告提供全球一般外科用設備的市場調查,彙整市場概要,市場規模的轉變·預測,類型·用途·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

目錄

第1章 序文

第2章 調查範圍·調查手法

第3章 摘要整理

第4章 簡介

第5章 全球一般外科用設備市場

  • 市場概要
  • 市場效能
  • COVID-19的影響

第6章 市場明細:各類型

  • 拋棄式手術用品
  • 剖腹手術
  • 能源為基礎的&電動設備
  • 微創手術器具
  • 粘連防止產品
  • 醫療用機器人工學·電腦導航手術設備

第7章 市場明細:各用途

  • 整形外科
  • 心臟病
  • 眼科
  • 創傷護理
  • 腦神經外
  • 泌尿系統·婦女手術
  • 其他

第8章 市場明細:各地區

  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東·非洲

第9章 SWOT分析

第10章 價值鏈分析

第11章 波特五力分析

第12章 價格分析

第13章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Conmed Corporation
    • Erbe Elektromedizin GmbH
    • Integer Holdings Corporation
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Olympus Corporations
    • Smith & Nephew plc
    • The 3M Company
目錄
Product Code: SR1020G243_Report

The global general surgery devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

General surgery devices are medical instruments used for performing routine procedures and complex surgeries. These devices are mainly utilized for cutting and dissecting, grasping and holding, clamping and occluding, exposing and retracting, suturing and stapling, viewing, and suctioning purposes. They are regularly maintained and sterilized by surgeons, dentists, and other healthcare providers who specialize in the diagnosis and operative administration of patient care. Presently, they are employed in the field of orthopedics, neurology, obstetrics, urology, and gynecology worldwide.

General Surgery Devices Market Trends:

Rising surgical procedures on account of the increasing number of individuals suffering from cardiac and gastrointestinal diseases represent one of the key factors contributing to the growth of the market. Apart from this, the growing geriatric population, which is more prone to perioperative complications, is also supporting the market. Moreover, government bodies of several countries are undertaking initiatives to provide advanced equipment for general surgery and training sessions. Furthermore, technological advancements in surgical procedures, such as the integration of robotics with artificial intelligence (AI), and the development of computer-assisted systems wherein the surgeon employs computer and software technology to control and move surgical instruments are offering growth opportunities to market players. Additionally, the increasing adoption of stem cell technology to treat chronic ailments, such as osteoarthritis and osteomyelitis, is strengthening the market growth. Other major factors anticipated to propel the growth of the market include increasing investments in the healthcare sector and the rising adoption of 3D printing technology in surgical procedures.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global general surgery devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type and application.

Breakup by Type:

  • Disposable Surgical Supplies
  • Open Surgery Instrument
  • Energy-based and Powered Instrument
  • Minimally Invasive Surgery Instruments
  • Adhesion Prevention Products
  • Medical Robotics and Computer Assisted Surgery Devices

Breakup by Application:

  • Orthopedic Surgery
  • Cardiology
  • Ophthalmology
  • Wound Care
  • Neurosurgery
  • Urology and Gynecology Surgery
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Erbe Elektromedizin GmbH, Integer Holdings Corporation, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Olympus Corporations, Smith & Nephew plc and The 3M Company.

Key Questions Answered in This Report:

  • How has the global general surgery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global general surgery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global general surgery devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global General Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Disposable Surgical Supplies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Open Surgery Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Energy-based and Powered Instrument
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Minimally Invasive Surgery Instruments
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Prevention Products
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Medical Robotics and Computer Assisted Surgery Devices
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Orthopedic Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ophthalmology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wound Care
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Neurosurgery
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Urology and Gynecology Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 B. Braun Melsungen AG
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Conmed Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Erbe Elektromedizin GmbH
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Integer Holdings Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Integra LifeSciences Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Johnson & Johnson
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Medtronic plc
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Olympus Corporations
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Smith & Nephew plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 The 3M Company
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis